Equillium (EQ) Return on Capital Employed (2018 - 2026)
Equillium's (EQ) quarterly Return on Capital Employed came in at 46.16% in Q1 2026, up 4845.0% year-on-year from 0.93% in Q1 2025, and up 40.9% on a QoQ basis from 78.1% in Q4 2025.
Equillium (EQ) Return on Capital Employed (2018 - 2026) Analysis & Trends
Equillium (EQ) has 9 years of Return on Capital Employed data on file, last reported at 46.16% in Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 4845.0% year-over-year to 46.16% in Q1 2026; TTM through Mar 2026 was 46.16%, a 4845.0% increase from a year earlier, with the FY2025 full-year figure at 91.56%, down 6549.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 46.16%, up from 78.1% in the prior quarter.
- Over the last five years, Return on Capital Employed for EQ reached as high as 24.53% in Q3 2024 and fell as low as 1632.72% in Q4 2022.
- Historically, Return on Capital Employed has averaged 244.25% across 5 years, with a median of 78.1% in 2025.
- Across the five-year window, Return on Capital Employed slumped 158550 bps in 2022 and surged 157533 bps in 2023, its largest moves.
- Year by year, Return on Capital Employed stood at 1632.72% in 2022, then jumped by 96 bps to 57.39% in 2023, then surged by 39 bps to 34.92% in 2024, then slumped by 124 bps to 78.1% in 2025, then soared by 41 bps to 46.16% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 46.16% in Q1 2026, 78.1% in Q4 2025, and 119.71% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -107.40% |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 10.46% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -68.84% |
| 10 | Equillium | 242.14 Mn | 242.14 Mn | - | -46.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.16% |
| Dec 31, 2025 | -78.10% |
| Sep 30, 2025 | -119.71% |
| Jun 30, 2025 | -279.33% |
| Mar 31, 2025 | -94.61% |
| Dec 31, 2024 | -34.92% |
| Sep 30, 2024 | -24.53% |
| Jun 30, 2024 | -42.12% |
| Mar 31, 2024 | -53.13% |
| Dec 31, 2023 | -57.39% |
| Sep 30, 2023 | -32.23% |
| Jun 30, 2023 | -47.17% |
| Mar 31, 2023 | -187.38% |
| Dec 31, 2022 | -1,632.72% |
| Sep 30, 2022 | -356.31% |
| Jun 30, 2022 | -904.83% |
| Mar 31, 2022 | -161.55% |
| Dec 31, 2021 | -47.22% |
| Sep 30, 2021 | -41.15% |
| Jun 30, 2021 | -33.58% |